Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aripiprazole in Psychosis Associated with Alzheimer's Dementia
NCT00041678Phase 3Completed
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization
- Start
- Jan 2000
- Primary completion
- Mar 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of aripiprazole in psychosis (4 arms), sponsored by Otsuka Pharmaceutical Development & Commercialization. Primary endpoint: Neuropsychiatric Inventory-Nursing Home Psychosis Subscale at 10 weeks. Started Jan 2000; status: completed.
02
Drugs
aripiprazole
03
Conditions
psychosis
Beyond the preview
Go deeper on NCT00041678.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00041678.